Cargando…
Sample size calculation in randomised phase II selection trials using a margin of practical equivalence
BACKGROUND: In rare cancers or subtypes of common cancers, a comparison of multiple promising treatments may be required. The selected treatment can then be assessed against the standard of care (if it exists) or used as a backbone for combinations with new, possibly targeted, agents. There could be...
Autores principales: | Dehbi, Hakim-Moulay, Hackshaw, Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106856/ https://www.ncbi.nlm.nih.gov/pubmed/32228674 http://dx.doi.org/10.1186/s13063-020-04248-8 |
Ejemplares similares
-
Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence
por: Dehbi, Hakim‐Moulay, et al.
Publicado: (2022) -
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
por: Dehbi, Hakim-Moulay, et al.
Publicado: (2017) -
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
por: Dehbi, Hakim-Moulay, et al.
Publicado: (2019) -
Sample size calculation
por: Kadam, Prashant, et al.
Publicado: (2010) -
Sample Size Calculation Guide - Part 6: How to calculate the sample size for a non-inferiority or an equivalence clinical trial
por: Negida, Ahmed
Publicado: (2019)